TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 131 filers reported holding TRICIDA INC in Q3 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $32,889 | -82.4% | 215,100 | +1108.4% | 0.00% | – |
| Q3 2022 | $187,000 | +92.8% | 17,800 | +78.0% | 0.00% | – |
| Q2 2022 | $97,000 | -44.6% | 10,000 | -69.8% | 0.00% | – |
| Q1 2021 | $175,000 | -34.2% | 33,100 | -12.4% | 0.00% | – |
| Q4 2020 | $266,000 | -26.7% | 37,800 | -5.7% | 0.00% | – |
| Q3 2020 | $363,000 | -67.9% | 40,100 | -2.7% | 0.00% | -100.0% |
| Q2 2020 | $1,132,000 | +61.3% | 41,200 | +29.2% | 0.00% | 0.0% |
| Q1 2020 | $702,000 | -43.8% | 31,900 | -3.6% | 0.00% | 0.0% |
| Q4 2019 | $1,249,000 | +22.2% | 33,100 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $1,022,000 | -21.7% | 33,100 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $1,306,000 | +89.0% | 33,100 | +84.9% | 0.00% | – |
| Q1 2019 | $691,000 | +171.0% | 17,900 | +65.7% | 0.00% | – |
| Q4 2018 | $255,000 | – | 10,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
| Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
| Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
| Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
| Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
| Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
| Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
| H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
| Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |